Dow Down3.39% Nasdaq Down4.12%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
0.93 Down 0.09(8.82%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 2,940   6,024   6,737   4,025  
Cost of Revenue -   -   -   -  
Gross Profit 2,940   6,024   6,737   4,025  
Operating Expenses
Research Development4,642  6,588  8,303  6,544  
Selling General and Administrative2,299  2,915  3,125  3,067  
Non Recurring431   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,432) (3,479) (4,691) (5,586)
Income from Continuing Operations
Total Other Income/Expenses Net725  1,755  141  (424)
Earnings Before Interest And Taxes(3,707)(1,724)(4,550)(6,010)
Interest Expense -   -   -   -  
Income Before Tax(3,707)(1,724)(4,550)(6,010)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,707)(1,724)(4,550)(6,010)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,707) (1,724) (4,550) (6,010)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,707) (1,724) (4,550) (6,010)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.